Medicaid said it won't pay for gender-affirming surgeries or hormones for transgender minors. The change, announced Tuesday, is the latest in a line of policies from President Donald Trump's administration targeting transgender people.

HHS finalized a rule prohibiting Medicaid payments for child gender medicine, including puberty blockers, cross-sex hormones, and surgeries.

El gobierno ha tomado la decisión al concluir que existen «importantes lagunas en la evidencia» que demostraba la seguridad de estos tratamientos